Hypoglycemic Response to Dorzagliatin in a Patient With GCK-MODY.
Yilin ZhaoYumin MaTianhao BaXueyao HanQian RenXiantong ZouPublished in: Diabetes care (2024)
Dorzagliatin was effective and safe in this patient with GCK-MODY, providing potential application prospects for precise treatment of GCK-MODY with dorzagliatin.
Keyphrases